Search
Search Results
##search.searchResults.foundPlural##
-
Peripheral Red Blood Cell Split Chimerism as a Consequence of Intramedullary Selective Apoptosis of Recipient Red Blood Cells in a Case of Sickle Cell Disease
1569PDF: 865HTML: 1854Untitled: 176Untitled: 156 -
-
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa
6649PDF: 3539HTML: 718 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
3714Suppl. Files: 1029PDF: 1015Html: 104 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3529PDF: 1357HTML: 166 -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5039PDF: 1286HTML: 2721Cover letter: 173 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
1875PDF: 1326HTML: 244 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
3957PDF: 1513HTML: 805 -
SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM
2152PDF: 825HTML: 2057 -
CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment
1638PDF: 785HTML: 137 -
NEW STRATEGIES FOR STEM CELL MOBILIZATION
2318PDF: 818HTML: 2437 -
TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2507PDF: 829HTML: 17436Fig1 Caligaris: 142Fig.2 Caliga: 176 -
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES
2048PDF: 1917HTML: 138 -
-
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
1962PDF: 1576HTML: 344 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
948PDF: 1067Suppl. Files: 550HTML: 71 -
WHAT UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA TAUGHT US ABOUT TRANSPLANT IMMUNOGENETICS.
3085PDF: 1097HTML: 1450Untitled: 159Untitled: 147Untitled: 147 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2425PDF: 808HTML: 8785Efremov 1: 204Efremov 2: 161 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3365PDF: 1441HTML: 63 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
2968PDF: 829HTML: 7148Kost Fig1: 163Kost Fig 2: 153Kost Fig3: 149Kost Fig 4: 166Kost Fig5: 162Kost fig 6: 149 -
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
2527PDF: 1027HTML: 95 -
How I treat acute and persistent sickle cell pain
1818PDF: 1077HTML: 456 -
-
ON THE VERSATILITY OF VON WILLEBRAND FACTOR
2725PDF: 1077HTML: 11204 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3640PDF: 1406HTML: 456Figures . Eliassian: 198 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3420PDF: 2323HTML: 1401 -
IMMUNOLOGY OF TUBERCULOSIS
5104PDF: 1952HTML: 7244Untitled: 185 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3096PDF: 1371HTML: 5830Fig1-Ag-Pil: 192Ag-Pil Fig.2: 195 -
VON WILLEBRAND FACTOR, ANGIODYSPLASIA AND ANGIOGENESIS
3639PDF: 1513HTML: 8000Randi Fig: 157 -
SICKLE CELL ANAEMIA AND MALARIA
11032PDF: 6780HTML: 23777Figures Malaria and SCK: 179 -
-
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2509PDF: 769HTML: 5172 -
IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE
2151PDF: 922HTML: 1867 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2184PDF: 1286HTML: 17047Bassan Fig.1: 133Bassan Fig.2: 129Bassan Fig.4: 125Fig.3: 162







